640 Combinatorial chemoimmunotherapy based on the antibody-cytokine fusion protein L19TNF unleashes potent anti-tumor immunity against treatment-refractory glioblastoma
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.